Clinical Trial Update: Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation

View source ↗

Summary

Clinical trial comparing cyclosporine versus tacrolimus after Campath induction in kidney transplantation is completed. Results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allograft Nephropathy
• Bk Virus Nephropathy
• Graft Rejection

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Russian Academy of Medical Sciences | Conditions: Acute Graft Rejection, Chronic Allograft Nephropathy | Status: COMPLETED | Results posted: 2016-11-29